0001494650-19-000031.txt : 20190306 0001494650-19-000031.hdr.sgml : 20190306 20190306182950 ACCESSION NUMBER: 0001494650-19-000031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190228 FILED AS OF DATE: 20190306 DATE AS OF CHANGE: 20190306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibbs Thomas Edward CENTRAL INDEX KEY: 0001639012 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38241 FILM NUMBER: 19663795 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVENUE NW STREET 2: SUITE 300E CITY: WASHINGTON STATE: DC ZIP: 20037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OptiNose, Inc. CENTRAL INDEX KEY: 0001494650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421771610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 STONY HILL ROAD STREET 2: SUITE 300 CITY: YARDLEY STATE: PA ZIP: 19067 BUSINESS PHONE: 267-364-3500 MAIL ADDRESS: STREET 1: 1020 STONY HILL ROAD STREET 2: SUITE 300 CITY: YARDLEY STATE: PA ZIP: 19067 4 1 wf-form4_155191497668547.xml FORM 4 X0306 4 2019-02-28 0 0001494650 OptiNose, Inc. OPTN 0001639012 Gibbs Thomas Edward C/O OPTINOSE, INC. 1020 STONY HILL ROAD, SUITE 300 YARDLEY PA 19067 0 1 0 0 Chief Commercial Officer Stock Option (Right to Buy) 7.42 2019-02-28 4 A 0 82500 0 A 2029-02-28 Common Stock 82500.0 82500 D The option vests and becomes exercisable over a four-year period commencing on February 28, 2019. Twenty-five percent (25%) of the option vests and becomes exercisable on February 28, 2020, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer. /s/ Leanne Kelly, attorney-in-fact 2019-03-06